Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.53 |
| ▸ | ACHE | P22303 | 3/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | CASP2 | P42575 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24412637 | 0.94 | CASP2 (0.53) | BCHEACHEDNM1NAAACASP2 | |
| SCHEMBL24412677 | 0.84 | THRA (0.42) | BCHEACHENAAACASP2EPHX1 | |
| SCHEMBL24412627 | 0.81 | CASP2 (0.54) | DNM1NAAACASP2EPHX1EPHX2 | |
| SCHEMBL24444406 | 0.81 | CASP2 (0.54) | DNM1NAAACASP2EPHX1EPHX2 | |
| SCHEMBL24412938 | 0.81 | CASP2 (0.54) | DNM1NAAACASP2EPHX1EPHX2 | |
| SCHEMBL24412733 | 0.81 | CASP2 (0.54) | DNM1NAAACASP2EPHX1EPHX2 | |
| SCHEMBL13677592 | 0.80 | BCHE (0.40) | BCHEACHEMAPT | |
| SCHEMBL13135931 | 0.79 | KDM4E (0.47) | BCHEACHENAAAEPHX1EPHX2 | |
| SCHEMBL24412628 | 0.79 | EPHX1 (0.50) | BCHEACHEDNM1NAAACASP2 | |
| SCHEMBL3188510 | 0.78 | ALDH1A1 (0.46) | BCHEACHEMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4001265-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | Shaoxing Ruikang Biotechnologies Co., Inc (CN) | 2022-05-25 | — | — | EP | disclosed |
| US-20220145045-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | SHAOXING RUIKANG BIOTECHNOLOGIES CO INC (CN) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220145045-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | PCNA, NCL, PNN | BCHE 1268/4885ACHE 2936/4885DNM1 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.